Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero® to reduce meningococcal group B disease in Germany

Autor: Christensen, Hannah, Irving, Tom, Koch, Judith, Trotter, Caroline L., Ultsch, Bernhard, Weidemann, Felix, Wichmann, Ole, Hellenbrand, Wiebke
Zdroj: In Vaccine 17 June 2016 34(29):3412-3419
Databáze: ScienceDirect